MONTGOMERY, ALA. (August 25, 2011) – Beasley, Allen, Crow, Methvin, Portis & Miles, P.C., attorney Ted Meadows, who practices in the firm’s Mass Torts section, was chosen to help direct litigation related to Hormone Replacement Therapy (HRT) as part of the Plaintiffs Steering Committee (PSC). The multidistrict Prempro Products Liability Litigation, involved thousands of cases against drug manufacturer Wyeth Pharmaceuticals, and was consolidated under U.S. District Judge Billy Roy Wilson in the United States District Court, Eastern District of Arkansas, Western Division.
Hormone Replacement Therapy, including drugs such as Premarin, Prempro and Provera, was prescribed to treat the symptoms of menopause until 2002, when a comprehensive women’s health study was halted as a result of increasing incidents of breast cancer. The drugs also were promoted for off-label uses, including prevention of cardiovascular disease and Alzheimer’s disease.
“By marketing these drugs for uses that were never approved by the FDA and downplaying the risk of breast cancer, Wyeth put the lives of thousands of women at serious risk,” Meadows said.
Related information: Verdict history shows juries find Wyeth downplayed breast cancer risk for HRT.
